•  
  •  
  •  
  •  

2025-08-08 22:04:07

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
  • Central Bank of India Launches Pioneering TReDS Insurance Policy In Strategic Partnership With TATA AIG
  • Bangur Concrete Launches First RMC Plant in Karnataka, Enters South India Market
  • Gateway Distriparks Signs Exclusive Container Train Operations Agreement for MMLP, Ankleshwar
  • RBI grants NBFC license to Equirus Group

Keywords Selected:  EdelweissFinancialServices

Stock Report

  • Edelweiss Financial Services Ltd Q1 FY2026 consolidated PAT drops QoQ to Rs. 66.77 crores
  • Edelweiss Financial Services Limited announces ₹ 3,000 million Public Issue of Secured Redeemable NCDs
  • Edelweiss Financial Services Limited recommends dividend of Rs. 1.50
  • Edelweiss Financial Services Ltd's consolidated profit in Q4FY25 at Rs. 105.34 crores
  • Edelweiss Financial Services Ltd announces ₹ 2,000 million Public Issue of Secured Redeemable NCDs
  • Edelweiss Financial Services Ltd announces Rs. 2,000 million Public Issue of Secured Redeemable NCDs
  • Edelweiss Financial Services Ltd Q1 FY2025 consolidated PAT declines QoQ to Rs. 58.89 crores
  • Edelweiss Financial Services Ltd invests further in Edelweiss Life Insurance Company Ltd
  • Edelweiss Financial Services Limited announces ₹ 2,000 million Public Issue of Secured Redeemable NCDs
  • Edelweiss Mutual Fund appoints Aniruddha Kekatpure as Head of Research
  • Edelweiss Tokio Life Insurance is now Edelweiss Life Insurance
  • Edelweiss Financial Services Ltd recommends dividend of Rs. 1.50
  • Edelweiss Financial Services Ltd posts consolidated Q4FY24 PAT of Rs. 169.11 crores
  • Edelweiss Financial Services Ltd announces Rs. 2,000 million Public Issue of Secured Redeemable NCDs
  • Edelweiss Financial Services Ltd announces ₹ 2,000 million Public Issue of Secured Redeemable NCDs
  • Edelweiss Financial Services Ltd announces ₹ 2,500 million Public Issue of Secured Redeemable NCDs
  • Edelweiss Tokio Life innovates risk management practices to strengthen business quality
  • Edelweiss Financial Services Ltd announces Public Issue of Secured Redeemable NCDs for an amount upto ₹2,000 million
  • RBI imposes penalty on Nido Home Finance Ltd
  • Edelweiss Alternatives launches its First Climate Fund
  • Edelweiss Financial Services Ltd consolidated Q1 FY2024 PAT declines QoQ to Rs. 50.54 crores
  • Edelweiss Financial Services announces ₹3,000 million Public Issue of Secured Redeemable NCDs
  • Edelweiss Financial Services Ltd recommends final dividend of Rs. 1.25
  • Edelweiss Financial Services Ltd Q4 FY23 consolidated net profit higher at Rs. 149.31 crores

Mutual Funds

  • Edelweiss Mutual Fund launches the 'Nifty Alpha Low Volatility 30 Index Fund'
  • Edelweiss Asset Management Launches Technology Fund
  • Edelweiss Mutual Fund launches Multi Cap Fund
  • Edelweiss MF Launches Edelweiss CRISIL IBX 50:50 Gilt Plus SDL September 2028
  • Edelweiss Asset Management Launches 'Edelweiss Focused Equity Fund'
  • Edelweiss Mutual Fund Launches 'Edelweiss Crisil PSU Plus SDL 50:50 Oct 2025 Index Fund'
  • Edelweiss MF Bharat Bond 3rd Tranche Oversubscribed by more than 6.2x
  • Edelweiss AMC launches Large and Midcap Index Fund

Latest Post

  • Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
  • Central Bank of India Launches Pioneering TReDS Insurance Policy In Strategic Partnership With TATA AIG
  • Bangur Concrete Launches First RMC Plant in Karnataka, Enters South India Market
  • Gateway Distriparks Signs Exclusive Container Train Operations Agreement for MMLP, Ankleshwar
  • RBI grants NBFC license to Equirus Group


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024